Clinical Trial Update: Ultrasensitive Electroanatomic Mapping to Adjudicate Endpoints for Ablation In Paroxysmal AF Patients Using Cryoballoon

View source ↗

Summary

A trial evaluating ultrasensitive electroanatomic mapping to adjudicate endpoints for cryoballoon ablation in paroxysmal atrial fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Snippet

Sponsor: BayCare Health System | Conditions: Paroxysmal Atrial Fibrillation | Status: WITHDRAWN